Accounting Manager

Valo Therapeutics, (ValoTx), is a spin-out from the IVTLab at the University of Helsinki, Finland. ValoTx was founded in 2016 and owns several patents for new and innovative approaches to treating cancer and infectious diseases.  Scientists at ValoTx are developing treatments based on (a) modified adenovirus(es) (which is a very common virus in the human population and responsible for many common colds) that allows for targeted tumour killing and lasting protection against infectious diseases. These new treatment methods hold